Category: India IPO Reviews and Updates

Hindustan Construction Company (HCC) is planning to raise about Rs 1,500 crore through an initial public offering (IPO) for the Lavasa project near Pune. It is free India’s first and largest hill city being developed by Lavasa Corporation an HCC Group Company.

The company is planning an IPO to fund the cost of the project and will be entering the (more…)

State-run National Hydro-electric Power Corporation is monitoring the market situation watchfully and is waiting for an opportune time for floating its initial public offer (IPO). Reacting to the news earlier surfaced about canceling the public offer, the management has contended that there was no plan of canceling IPO but it was considering deferring till a suitable time is reached. (more…)

After being unsuccessful in 2008 to raise Rs 75,000 crore through initial public offering (IPO) route, over three dozen firms are holding back IPO plans to raise an estimated Rs 75,000 crore or over $15 billion for the right market conditions, which analysts believe is unlikely before the year-end.

The overall size of the IPO backlog from 2008 is incidentally more than four times of the total amount raised during the year through this route and almost equals the cumulative capital raised over the past three years. (more…)

During the Euphoria on Dalal Street early this year, me too for a BIG IPO / Follow on Public Offering, Rights Issue, AIM Listing was the mantra in corporate boardrooms. Digging into our database we have found several companies have SEBI approval for big fund raising. here is the except, (more…)

Alkali Metals Limited (AML) is engaged in the manufacturing of a range of fine, based on related chemistry. Currently, the company has two manufacturing facilities, each having an installed capacity of 2200 MTPA. The Unit I is engaged in the manufacture of sodium metals, organo alkali metallics, tetrazoles, amino pyridines and caters to the domestic market and Unit II, a 100% EOU is engaged in the manufacture of pyridine derivatives, cyclic compounds and fine chemicals. (more…)

We have obtained the basis of Allotment of Chemcel Biotech IPO for Retail and HNI Category. For, institutions, I believe they are calling and informing the pattern of allocation in such terrible market conditions. WoW!!! Investors Rule. (more…)